Sofosbuvir-Based Direct-Acting Antiviral Therapies for HCV in People Receiving Opioid Substitution Therapy: An Analysis of Phase 3 Studies

BACKGROUND: Hepatitis C virus (HCV) direct-acting antiviral therapy is effective among people receiving opioid substitution therapy (OST), but studies are limited by small numbers of nongenotype 1 (GT1) patients. The aim of this study was to evaluate the treatment completion, adherence, SVR12, and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Grebely, Jason, Feld, Jordan J, Wyles, David, Sulkowski, Mark, Ni, Liyun, Llewellyn, Joe, Mir, Heshaam M, Sajed, Nika, Stamm, Luisa M, Hyland, Robert H, McNally, John, Brainard, Diana M, Jacobson, Ira, Zeuzem, Stefan, Bourlière, Marc, Foster, Graham, Afdhal, Nezam, Dore, Gregory J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808802/
https://www.ncbi.nlm.nih.gov/pubmed/29450210
http://dx.doi.org/10.1093/ofid/ofy001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808802/
https://www.ncbi.nlm.nih.gov/pubmed/29450210
http://dx.doi.org/10.1093/ofid/ofy001

Ejemplares similares